BlackRock Health Sciences Trust (NYSE:BME) Short Interest Update
by Amy Steele · The Cerbat GemBlackRock Health Sciences Trust (NYSE:BME – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 30,636 shares, a growth of 146.0% from the November 30th total of 12,455 shares. Based on an average daily trading volume, of 37,256 shares, the short-interest ratio is presently 0.8 days. Based on an average daily trading volume, of 37,256 shares, the short-interest ratio is presently 0.8 days.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Shaker Financial Services LLC bought a new position in shares of BlackRock Health Sciences Trust in the 2nd quarter valued at $8,186,000. Cypress Capital Management LLC WY acquired a new stake in BlackRock Health Sciences Trust in the second quarter valued at about $1,405,000. Bank of America Corp DE grew its position in BlackRock Health Sciences Trust by 18.8% in the third quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after acquiring an additional 34,218 shares during the last quarter. Consolidated Portfolio Review Corp grew its position in BlackRock Health Sciences Trust by 40.2% in the third quarter. Consolidated Portfolio Review Corp now owns 54,522 shares of the company’s stock valued at $2,030,000 after acquiring an additional 15,643 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in shares of BlackRock Health Sciences Trust by 7.6% in the 3rd quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock valued at $8,085,000 after purchasing an additional 15,381 shares in the last quarter.
BlackRock Health Sciences Trust Trading Up 0.0%
Shares of BlackRock Health Sciences Trust stock traded up $0.00 during trading on Friday, reaching $41.41. The company’s stock had a trading volume of 28,659 shares, compared to its average volume of 48,323. The business’s 50-day moving average price is $39.94 and its 200-day moving average price is $37.70. BlackRock Health Sciences Trust has a 52 week low of $34.18 and a 52 week high of $41.72.
BlackRock Health Sciences Trust Dividend Announcement
The firm also recently disclosed a monthly dividend, which will be paid on Wednesday, December 31st. Shareholders of record on Monday, December 22nd will be issued a $0.2621 dividend. The ex-dividend date of this dividend is Monday, December 22nd. This represents a c) dividend on an annualized basis and a yield of 7.6%.
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.